Skip to main content
Premium Trial:

Request an Annual Quote

Becton Dickinson Monkeypox PCR Assay Granted FDA Emergency Use Authorization

NEW YORK – The US Food and Drug Administration has granted Emergency Use Authorization for Becton Dickinson’s monkeypox PCR test.

The assay, Viasure Monkeypox virus Real-Time PCR Reagents for BD Max System, is designed to qualitatively detect monkeypox virus DNA in human lesion swab samples from individuals suspected of monkeypox infection by their healthcare provider. While positive results are indicative of the presence of monkeypox virus DNA, clinical correlation with patient history and other diagnostic information is necessary to determine patient infection status, the FDA said.

Since September, the FDA has been issuing EUAs for monkeypox tests. So far, Thermo Fisher, Quest Diagnostics, Roche, and Abbott have also nabbed EUAs for their monkeypox assays.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.